LIC Introduces Three Insurance Products for Guaranteed Income, Health Protection and Cancer Coverage

LIC Expands Insurance Portfolio With Three New Protection and Income Products

Life Insurance Corporation of India (LIC), the country's largest life insurer, has introduced three new insurance products covering guaranteed income, health-related financial protection and cancer-specific coverage, broadening its offerings for customers with different financial security requirements.

The launches reflect LIC's efforts to address demand for predictable income arrangements and protection against major health-related financial risks.

The three products target different customer needs, ranging from long-term financial planning to support during serious illness.

Guaranteed income products are generally designed to provide defined benefits according to policy terms, while health-focused insurance products aim to reduce the financial consequences of specified medical events.

Cancer-specific protection plans address a narrower category of health risk and may provide benefits following a qualifying diagnosis, subject to policy conditions.

The new offerings expand LIC's product range at a time when insurance companies are seeking to improve coverage options and reach customers with different financial priorities.

LIC Names Three New Plans, With Sales Beginning October 19

LIC announced the products on October 13, 2026, with CEO and Managing Director R. Doraiswamy formally introducing the plans.

The three policies will become available for purchase in the Indian market from October 19, 2026.

All three are non-participating and non-linked insurance products.

Non-participating policies do not share in the insurer's distributable profits through participating bonuses, while non-linked products do not have benefits directly tied to investment fund performance.

The three plans serve different purposes, allowing customers to select products based on retirement income requirements, hospitalisation-related financial needs or cancer protection.

LIC's New Jeevan Dhara-II Offers Guaranteed Retirement Income

New Jeevan Dhara-II, designated Plan 892, is an individual savings and deferred annuity product.

The plan is designed to provide regular income after the completion of a selected deferment period.

Annuity rates are guaranteed at policy inception, giving policyholders greater certainty about future income payments under the selected option.

The product offers both regular-premium and single-premium payment choices.

Customers can also select between single-life and joint-life annuity arrangements, depending on their retirement planning requirements.

A notable feature is the option to purchase additional annuity benefits through top-up premium payments during the deferment period.

The available deferment period ranges from two to 15 years for regular-premium policies and one to 15 years for single-premium policies.

Eligibility and annuity commencement ages depend on the selected option.

The plan may appeal to customers seeking a predictable retirement income stream rather than market-linked investment returns.

However, policyholders should evaluate the annuity rate, premium commitment, payout frequency and treatment of benefits following death before purchasing.

LIC's Health Shield Provides Fixed Benefits for Medical Events

Health Shield, designated Plan 907, is an individual, non-linked, non-participating health insurance product structured as a pure-risk plan.

The product offers fixed financial benefits for specified medical events.

Its principal features include a daily hospital cash benefit during eligible hospitalisation and lump-sum payments for covered major surgeries and critical illnesses.

The plan also provides options for family coverage.

LIC has indicated that premiums are guaranteed throughout the policy term, subject to the product's conditions.

The principal insured can enter the plan between ages 18 and 65, while eligible children may be covered under the family arrangement.

Unlike a conventional indemnity-based health insurance policy, which reimburses eligible medical expenses according to policy limits, a fixed-benefit product pays specified amounts when covered conditions are met.

This distinction matters because the benefit received may be higher or lower than the actual medical bill.

Health Shield may therefore serve as supplementary financial protection, but buyers should not assume it replaces comprehensive hospitalisation insurance.

LIC's New Cancer Cover Provides Diagnosis-Based Financial Protection

New Cancer Cover, designated Plan 908, is a cancer-specific health insurance product designed to provide financial assistance following diagnosis of specified cancers.

The policy covers qualifying early-stage and major-stage cancer diagnoses according to its definitions and conditions.

Benefits are based on the applicable sum assured rather than the actual cost of medical treatment.

This structure can provide flexibility because eligible payouts are not necessarily restricted to reimbursement of hospital bills.

The plan also includes a monthly income benefit following a qualifying major-stage cancer diagnosis.

Under the announced terms, the monthly benefit equals 1% of the applicable sum assured and is payable for 10 years, subject to policy conditions.

If the insured person dies during the relevant payment period, the benefit may continue to the nominee according to the policy provisions.

The product also includes a premium-waiver feature associated with qualifying claims.

Customers should carefully review the definitions of early-stage and major-stage cancer, exclusions, waiting periods and claim requirements before selecting coverage.

Why LIC Is Expanding Into Targeted Protection Products

The introduction of three products reflects the different financial risks faced by Indian households.

Retirement planning requires dependable income arrangements, particularly for individuals seeking to supplement pensions, savings or other sources of income.

Health-related financial risks create a different requirement, involving access to funds during hospitalisation, surgery or serious illness.

Cancer-specific insurance addresses another concern: the financial consequences of prolonged treatment, recovery and possible disruption to household income.

By introducing separate products for these needs, LIC is broadening its offering beyond traditional life insurance and savings policies.

The strategy also gives the insurer opportunities to reach customers who may already hold life insurance but require additional financial protection.

Guaranteed Annuity Income and Health Insurance Serve Different Purposes

Although all three products fall within LIC's insurance portfolio, they should not be evaluated as interchangeable financial instruments.

A deferred annuity plan is primarily designed to generate income at a later stage of life.

The policyholder contributes premiums or a purchase amount in exchange for annuity payments under the selected contractual terms.

A fixed-benefit health plan is intended to provide financial assistance when specified medical conditions or events occur.

A cancer-specific plan focuses on a defined group of illnesses and pays benefits when its diagnostic and policy conditions are satisfied.

These differences affect how customers should assess premiums, benefits and suitability.

A retirement annuity should be compared with other retirement income arrangements, while health protection plans should be evaluated alongside existing medical insurance and household financial resources.

Cancer Insurance Can Supplement Broader Health Coverage

Cancer treatment may involve expenses extending beyond a single hospital admission.

Depending on the diagnosis and treatment pathway, patients may face costs associated with investigations, medication, surgery, follow-up care and other medical requirements.

There may also be financial consequences from interrupted employment or reduced household income.

A fixed-benefit cancer policy can provide funds after a qualifying diagnosis, potentially helping customers manage expenses that are not fully addressed by reimbursement-based insurance.

However, cancer-specific coverage is limited to the conditions defined in the policy.

It does not provide protection against every illness or medical emergency.

Customers should therefore assess whether a cancer-specific policy complements their existing health coverage rather than treating it as a universal substitute.

What Customers Should Check Before Buying LIC's New Plans

Prospective policyholders should examine the detailed product documents once the plans become available.

For New Jeevan Dhara-II, important considerations include the premium amount, guaranteed annuity rate, deferment period, available payout options and benefits payable to nominees.

For Health Shield, customers should review the daily hospital cash amount, covered surgeries, critical illness definitions, waiting periods and family eligibility conditions.

For New Cancer Cover, the definitions of covered cancers, stage-based benefits, exclusions and monthly income provisions require particular attention.

Across all three products, affordability and long-term suitability are essential.

Guaranteed benefits are valuable only when customers understand the conditions under which they become payable.

Insurance buyers should also distinguish between a fixed contractual benefit and a reimbursement arrangement based on actual expenses.

LIC to Offer Plans Through Online and Offline Channels

The three insurance products will be available for purchase from October 19, 2026.

Customers will be able to access the products through LIC's distribution network, including authorised insurance agents and other permitted intermediaries.

Online purchase options will also be available through LIC's official website.

The use of multiple distribution channels allows the insurer to reach customers with different purchasing preferences.

Some buyers may prefer assisted sales because annuity structures and critical illness insurance conditions can require detailed explanation.

Others may prefer digital access for reviewing product information and completing eligible purchases.

Regardless of the distribution channel, customers should rely on the official policy wording and benefit illustrations when making decisions.

Implications for India's Insurance Industry

The new product launches highlight the growing importance of specialised financial protection within India's insurance market.

Traditional life insurance products remain important for family protection and long-term savings.

However, demand for retirement income, health-related benefits and critical illness protection creates opportunities for more differentiated insurance offerings.

For insurers, such products can support portfolio diversification and provide access to additional customer segments.

For customers, a wider range of products can improve choice, although greater complexity also makes transparent product communication important.

LIC's new offerings demonstrate how established life insurers are developing products for specific financial needs.

Their commercial performance will depend on customer adoption, distribution effectiveness, pricing and the clarity of policy benefits.

What Investors Should Monitor

For investors in LIC, the introduction of new products is relevant to the company's business development strategy.

Product diversification may support new business generation and create opportunities for additional premium income.

However, a product launch does not automatically establish future sales volumes or profitability.

Investors will need to assess customer demand, premium collections, product margins and the insurer's experience with claims.

The performance of annuity and health-related products may also differ from traditional savings and protection policies.

Future financial disclosures will provide a clearer picture of whether the new offerings contribute meaningfully to LIC's growth and business mix.

Conclusion

Life Insurance Corporation of India's introduction of New Jeevan Dhara-II, Health Shield and New Cancer Cover expands its portfolio across retirement income, general health protection and cancer-specific financial assistance.

The three products were introduced on October 13, 2026, and are scheduled to become available for purchase from October 19.

New Jeevan Dhara-II offers guaranteed annuity rates and retirement income options, while Health Shield provides fixed benefits for specified hospitalisation and medical events.

New Cancer Cover offers diagnosis-based benefits, including a monthly income provision following qualifying major-stage cancer diagnoses.

The launches strengthen LIC's range of specialised insurance products and provide customers with additional financial planning choices.

However, selecting the appropriate policy requires careful consideration of eligibility, premiums, exclusions, payout conditions and existing insurance coverage.

The products' longer-term significance will depend on customer adoption and their contribution to LIC's insurance business.